Voltar
Artigo Acesso aberto Produção Nacional Revisado por pares
BIBTEX RIS

Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction

2018; American Medical Association; Volume: 3; Issue: 5 Linguagem: Inglês

10.1001/jamacardio.2018.0612

ISSN

2380-6591

Autores

Otávio Berwanger, José Carlos Nicolau, Antônio Carlos Carvalho, Lixin Jiang, Shaun G. Goodman, Stephen J. Nicholls, Alexander Parkhomenko, О. В. Аверков, Carlos Tajer, Germán Málaga, José Francisco Kerr Saraiva, Francisco Antônio Helfenstein Fonseca, Fábio Augusto de Luca, Hélio Penna Guimarães, Pedro Gabriel Melo de Barros e Silva, Lucas Petri Damiani, Denise Paisani, Camila M. R. Lasagno, Carolina T. Candido, Nanci Valeis, Diogo D.F. Moia, Leopoldo Soares Piegas, Christopher B. Granger, Harvey D. White, Renato D. Lópes,

Tópico(s)

Atrial Fibrillation Management and Outcomes

Resumo

The bleeding safety of ticagrelor in patients with ST-elevation myocardial infarction treated with fibrinolytic therapy remains uncertain.

Referência(s)